IL126837A0 - Therapeutic treatment for vegf related diseases - Google Patents

Therapeutic treatment for vegf related diseases

Info

Publication number
IL126837A0
IL126837A0 IL12683797A IL12683797A IL126837A0 IL 126837 A0 IL126837 A0 IL 126837A0 IL 12683797 A IL12683797 A IL 12683797A IL 12683797 A IL12683797 A IL 12683797A IL 126837 A0 IL126837 A0 IL 126837A0
Authority
IL
Israel
Prior art keywords
therapeutic treatment
related diseases
vegf related
vegf
diseases
Prior art date
Application number
IL12683797A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL126837A0 publication Critical patent/IL126837A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12683797A 1996-05-01 1997-05-01 Therapeutic treatment for vegf related diseases IL126837A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1665896P 1996-05-01 1996-05-01
US84163597A 1997-04-30 1997-04-30
PCT/US1997/007752 WO1997040830A1 (en) 1996-05-01 1997-05-01 Therapeutic treatment for vegf related diseases

Publications (1)

Publication Number Publication Date
IL126837A0 true IL126837A0 (en) 1999-09-22

Family

ID=26688913

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12683797A IL126837A0 (en) 1996-05-01 1997-05-01 Therapeutic treatment for vegf related diseases

Country Status (15)

Country Link
US (1) US6284751B1 (ja)
EP (1) EP0915698A4 (ja)
JP (1) JP2002504086A (ja)
KR (1) KR20000065171A (ja)
CN (1) CN1233177A (ja)
AU (1) AU736333B2 (ja)
BR (1) BR9710706A (ja)
CA (1) CA2253608A1 (ja)
CZ (1) CZ350098A3 (ja)
EA (1) EA001779B1 (ja)
IL (1) IL126837A0 (ja)
NO (1) NO985066L (ja)
NZ (1) NZ332645A (ja)
PL (1) PL329851A1 (ja)
WO (1) WO1997040830A1 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093740A (en) * 1997-04-30 2000-07-25 Eli Lilly And Company Therapeutic treatment for skin disorders
US6103713A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for autoimmune diseases
US6103712A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for asthma
US6979441B2 (en) * 1998-09-16 2005-12-27 Wilson T Crandall Method for topical treatment of carpal tunnel syndrome
US6306383B1 (en) * 1998-09-16 2001-10-23 Wilson T Crandall Method for topical treatment of scars with protein kinase C inhibitors
US6921763B2 (en) 1999-09-17 2005-07-26 Abbott Laboratories Pyrazolopyrimidines as therapeutic agents
CN1422262A (zh) 2000-02-07 2003-06-04 艾博特股份有限两合公司 2－苯并噻唑基脲衍生物及其作为蛋白激酶抑制剂的应用
WO2002028387A1 (en) 2000-10-03 2002-04-11 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
US6875165B2 (en) 2001-02-22 2005-04-05 Retinalabs, Inc. Method of radiation delivery to the eye
MXPA03008560A (es) 2001-03-22 2004-06-30 Abbot Gmbh & Co Kg Pirazolopirimidinas como agentes terapeuticos.
NZ546088A (en) 2003-08-27 2009-10-30 Ophthotech Corp Combination therapy for the treatment of ocular neovascular disorders using a PDGF antagonist and a VEGF antagonist
ATE488269T1 (de) 2004-02-12 2010-12-15 Neovista Inc Gerät für die intraokulare brachytherapie
PL1734996T3 (pl) 2004-04-02 2013-09-30 Univ California Sposoby i kompozycje do leczenia i profilaktyki choroby związanej z integryną alfa v beta 5
DK1740591T3 (da) 2004-04-02 2009-10-26 Osi Pharm Inc Heterobicykliske proteinkinaseinhibitorer substitueret med en 6,6-biocyclisk ring
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
TW200613306A (en) 2004-07-20 2006-05-01 Osi Pharm Inc Imidazotriazines as protein kinase inhibitors
CA2629478C (en) * 2005-11-14 2013-10-15 Universitat Zurich Staurosporine derivatives for use in alveolar rhabdomyosarcoma
CN102512281A (zh) 2005-11-15 2012-06-27 内奥维斯塔公司 用于眼内近距离治疗的方法和器具
AR057960A1 (es) 2005-12-02 2007-12-26 Osi Pharm Inc Inhibidores de proteina quinasa biciclicos
EP2050441A1 (en) * 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
AU2014201660B2 (en) * 2007-10-19 2015-09-03 Centre Hospitalier Universitaire De Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
CA2724327A1 (en) 2008-06-04 2009-12-10 Neovista, Inc. Handheld radiation delivery system for advancing a radiation source wire
WO2013043644A1 (en) * 2011-09-21 2013-03-28 The University Of North Carolina At Chapel Hill Methods using liver disease biomarkers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK278989B6 (sk) 1988-02-10 1998-05-06 F. Hoffmann-La Roche Ag Substituované pyroly, ich použitie na výrobu lieči
DK0699204T3 (da) * 1993-05-28 1999-02-22 Cephalon Inc Anvendelse af indolocarbazolderivater til behandling af en patologisk tilstand i prostata
US5624949A (en) 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
DE69418978T2 (de) 1993-12-07 1999-10-28 Eli Lilly And Co., Indianapolis Synthese von Bisindolylmaleimiden
PT657458E (pt) * 1993-12-07 2002-02-28 Lilly Co Eli Inibidores de proteina cinase c
US5545636A (en) 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors

Also Published As

Publication number Publication date
NZ332645A (en) 2000-07-28
JP2002504086A (ja) 2002-02-05
PL329851A1 (en) 1999-04-12
WO1997040830A1 (en) 1997-11-06
EP0915698A1 (en) 1999-05-19
EA001779B1 (ru) 2001-08-27
US6284751B1 (en) 2001-09-04
CN1233177A (zh) 1999-10-27
KR20000065171A (ko) 2000-11-06
NO985066L (no) 1998-12-21
AU2935597A (en) 1997-11-19
NO985066D0 (no) 1998-10-30
CZ350098A3 (cs) 1999-11-17
EP0915698A4 (en) 1999-08-11
EA199800969A1 (ru) 1999-06-24
BR9710706A (pt) 1999-08-17
CA2253608A1 (en) 1997-11-06
AU736333B2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
IL126837A0 (en) Therapeutic treatment for vegf related diseases
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
ZA971937B (en) Combinations for treatment of proliferative diseases.
AU3949997A (en) Improved apparatus for ultrasonic therapeutic treatment
GB9601724D0 (en) Therapeutic agents
GB9600235D0 (en) Therapeutic agents
GB9603755D0 (en) Therapeutic agents
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
GB9419021D0 (en) Therapeutic protein
EP1039883A4 (en) METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES
GB9613969D0 (en) Therapeutic agents
GB9615449D0 (en) Therapeutic agents
GB9605065D0 (en) Therapeutic agents
GB9609374D0 (en) Therapeutic agents
IL136953A0 (en) Apparatus for therapeutic electromagnetic treatment
EP0878200A4 (en) THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
GB9610979D0 (en) Therapeutic agents
SI0918519T1 (en) Therapeutic treatment for vegf related occular diseases
GB0020261D0 (en) Therapeutic treatment
GB9603136D0 (en) Therapeutic agents
GB9604036D0 (en) Therapeutic agents
ZA987960B (en) Methods for treating ocular diseases
ZA982994B (en) Therapeutic treatment

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees